Symbols / HNGE Stock $43.99 -1.68% Hinge Health, Inc.

Healthcare • Health Information Services • United States • NYQ
HNGE (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. Daniel A. Perez
Exch · Country NYQ · United States
Market Cap 3.46B
Enterprise Value 3.37B
Income -424.09M
Sales 587.86M
FCF (ttm) 406.80M
Book/sh 2.26
Cash/sh 4.62
Employees 1,437
Insider 10d
IPO May 22, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E 18.95
PEG
P/S 5.89
P/B 19.49
P/C
EV/EBITDA -6.19
EV/Sales 5.73
Quick Ratio 1.19
Current Ratio 1.47
Debt/Eq 2.12
LT Debt/Eq
EPS (ttm) -7.77
EPS next Y 2.32
EPS Growth -80.80%
Revenue Growth 45.60%
EPS Gr Q/Q 18.40%
Rev Gr Q/Q
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-10
ROA -48.16%
ROE -132.86%
ROIC
Gross Margin 79.83%
Oper. Margin 15.96%
Profit Margin -89.86%
Shs Outstand 54.64M
Shs Float 39.63M
Insider Own 11.19%
Instit Own 100.66%
Short Float 7.35%
Short Ratio 5.04
Short Interest 3.96M
52W High 62.18
vs 52W High -29.25%
52W Low 30.08
vs 52W Low 46.24%
Beta
Impl. Vol. 85.62%
Rel Volume 0.69
Avg Volume 1.20M
Volume 833.73K
Target (mean) $57.53
Tgt Median $59.00
Tgt Low $43.00
Tgt High $72.00
# Analysts 15
Recom Buy
Prev Close $44.74
Price $43.99
Change -1.68%
About

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$43.99
Low
$43.00
High
$72.00
Mean
$57.53

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-08 main Evercore ISI Group Outperform → Outperform $45
2026-03-11 main RBC Capital Outperform → Outperform $55
2026-02-11 main Canaccord Genuity Buy → Buy $53
2026-02-11 main RBC Capital Outperform → Outperform $50
2026-02-11 reit Citizens Market Outperform → Market Outperform $65
2026-02-11 main Evercore ISI Group Outperform → Outperform $50
2026-02-11 main Barclays Overweight → Overweight $52
2026-02-11 reit Needham Buy → Buy $59
2026-01-23 init Freedom Capital Markets — → Buy $59
2026-01-09 main Piper Sandler Overweight → Overweight $60
2026-01-09 init Wells Fargo — → Overweight $68
2026-01-08 main Keybanc Overweight → Overweight $70
2026-01-06 reit Needham Buy → Buy $59
2026-01-05 main Barclays Overweight → Overweight $60
2025-11-05 main Canaccord Genuity Buy → Buy $65
2025-11-05 main Barclays Overweight → Overweight $65
2025-11-05 reit Piper Sandler Overweight → Overweight $71
2025-10-08 main Evercore ISI Group Outperform → Outperform $65
2025-09-23 main Morgan Stanley Overweight → Overweight $67
2025-09-11 main Stifel Buy → Buy $66
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-21 MECKLENBURG GABRIEL M.I. Director 33,333 $45.05 $1,501,528
2026-04-21 MECKLENBURG GABRIEL M.I. Director 33,333
2026-04-02 SLOAT TYLER Director 68 $42.40 $2,883
2026-04-01 MECKLENBURG GABRIEL M.I. Director 50,000 $38.45 $1,922,780
2026-04-01 MECKLENBURG GABRIEL M.I. Director 50,000
2026-03-23 BUDGE JAMES W. Chief Financial Officer 11,006 $41.29 $465,139
2026-03-23 PURSLEY JAMES President 15,000 $41.21 $633,927
2026-03-16 SLOAT TYLER Director 9,896 $0.00 $0
2026-03-06 MECKLENBURG GABRIEL M.I. Director 166,666 $45.02 $7,552,645
2026-03-06 MECKLENBURG GABRIEL M.I. Director 166,666
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Revenue
587.86
+50.58%
390.40
+33.37%
292.73
Operating Revenue
587.86
+50.58%
390.40
+33.37%
292.73
Cost Of Revenue
119.64
+32.19%
90.50
-8.17%
98.55
Reconciled Cost Of Revenue
119.64
+32.19%
90.50
-8.17%
98.55
Gross Profit
468.22
+56.13%
299.90
+54.45%
194.18
Operating Expense
1,014.59
+205.77%
331.81
+2.19%
324.69
Research And Development
368.14
+265.07%
100.84
-8.38%
110.06
Selling General And Administration
646.46
+179.88%
230.97
+7.61%
214.63
Selling And Marketing Expense
316.95
+89.73%
167.06
+13.17%
147.62
General And Administrative Expense
329.50
+415.54%
63.91
-4.63%
67.02
Other Gand A
329.50
+415.54%
63.91
-4.63%
67.02
Total Expenses
1,134.23
+168.58%
422.31
-0.22%
423.24
Operating Income
-546.37
-1612.23%
-31.91
+75.55%
-130.51
Total Operating Income As Reported
-546.37
-1612.23%
-31.91
+75.55%
-130.51
EBITDA
-541.24
-1984.89%
-25.96
+79.21%
-124.89
Normalized EBITDA
-541.24
-1984.89%
-25.96
+79.21%
-124.89
Reconciled Depreciation
5.13
-13.73%
5.95
+5.74%
5.63
EBIT
-546.37
-1612.23%
-31.91
+75.55%
-130.51
Net Income
-528.26
-4326.89%
-11.93
+88.97%
-108.14
Pretax Income
-527.26
-4584.28%
-11.26
+89.63%
-108.55
Other Income Expense
19.11
-7.49%
20.65
-5.98%
21.97
Other Non Operating Income Expenses
19.11
-7.49%
20.65
-5.98%
21.97
Tax Provision
1.00
+47.42%
0.68
+267.16%
-0.41
Tax Rate For Calcs
0.00
+0.00%
0.00
+5150.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-528.26
-4326.89%
-11.93
+88.97%
-108.14
Net Income From Continuing Operation Net Minority Interest
-528.26
-4326.89%
-11.93
+88.97%
-108.14
Net Income From Continuing And Discontinued Operation
-528.26
-4326.89%
-11.93
+88.97%
-108.14
Net Income Continuous Operations
-528.26
-4326.89%
-11.93
+88.97%
-108.14
Normalized Income
-528.26
-4326.89%
-11.93
+88.97%
-108.14
Net Income Common Stockholders
-424.09
-3453.90%
-11.93
+88.97%
-108.14
Otherunder Preferred Stock Dividend
-104.17
0.00
0.00
Diluted EPS
-0.15
+90.31%
-1.58
Basic EPS
-0.15
+90.31%
-1.58
Basic Average Shares
78.02
+13.83%
68.54
Diluted Average Shares
78.02
-15.11%
91.90
Diluted NI Availto Com Stockholders
-424.09
-3453.90%
-11.93
+88.97%
-108.14
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Assets
744.76
+10.62%
673.26
+8.15%
622.53
Current Assets
533.90
-8.49%
583.45
+10.11%
529.88
Cash Cash Equivalents And Short Term Investments
363.86
-22.01%
466.57
+10.21%
423.36
Cash And Cash Equivalents
208.00
-30.85%
300.79
+28.02%
234.95
Cash Equivalents
167.57
-36.44%
263.66
+29.94%
202.90
Cash Financial
40.43
+8.89%
37.13
+15.83%
32.05
Other Short Term Investments
155.87
-5.98%
165.79
-12.00%
188.40
Receivables
66.06
+55.46%
42.49
-8.74%
46.56
Accounts Receivable
51.04
+35.53%
37.66
+26.57%
29.75
Gross Accounts Receivable
48.97
-2.07%
50.00
Allowance For Doubtful Accounts Receivable
-6.47
-88.14%
-3.44
Receivables Adjustments Allowances
-6.09
+5.84%
-6.47
-88.14%
-3.44
Other Receivables
21.12
+86.75%
11.31
-44.16%
20.25
Inventory
15.64
+43.81%
10.87
-18.21%
13.29
Raw Materials
6.56
+35.71%
4.83
+167.81%
1.80
Work In Process
0.12
-93.93%
1.91
-44.14%
3.42
Finished Goods
8.96
+117.05%
4.13
-48.83%
8.07
Prepaid Assets
30.93
+29.35%
23.91
+66.57%
14.36
Current Deferred Assets
50.94
+56.03%
32.65
+16.83%
27.95
Other Current Assets
6.47
-6.80%
6.95
+59.06%
4.37
Total Non Current Assets
210.86
+134.77%
89.81
-3.06%
92.65
Net PPE
17.35
+2.14%
16.99
-24.43%
22.48
Gross PPE
37.13
+10.67%
33.55
-2.04%
34.25
Accumulated Depreciation
-19.78
-19.42%
-16.56
-40.71%
-11.77
Properties
0.00
0.00
0.00
Machinery Furniture Equipment
30.07
+26.65%
23.74
+14.18%
20.79
Other Properties
6.86
-28.58%
9.61
-27.53%
13.26
Leases
0.20
+0.00%
0.20
+0.00%
0.20
Goodwill And Other Intangible Assets
66.61
+5.04%
63.41
-0.59%
63.79
Goodwill
64.10
+4.04%
61.61
+0.00%
61.61
Other Intangible Assets
2.51
+39.01%
1.81
-17.30%
2.19
Investments And Advances
113.17
0.00
Other Non Current Assets
13.73
+45.84%
9.41
+47.59%
6.38
Total Liabilities Net Minority Interest
366.23
+42.75%
256.56
+31.40%
195.25
Current Liabilities
362.41
+45.37%
249.30
+35.37%
184.16
Payables And Accrued Expenses
45.87
+93.63%
23.69
-27.50%
32.68
Payables
6.17
+190.94%
2.12
-74.14%
8.20
Current Accrued Expenses
39.70
+84.07%
21.57
-11.88%
24.48
Pensionand Other Post Retirement Benefit Plans Current
11.46
+175.26%
4.16
-34.62%
6.37
Total Tax Payable
6.17
+190.94%
2.12
-74.14%
8.20
Current Debt And Capital Lease Obligation
4.22
+10.72%
3.81
-17.75%
4.64
Current Capital Lease Obligation
4.22
+10.72%
3.81
-17.75%
4.64
Current Deferred Liabilities
300.86
+38.24%
217.63
+54.93%
140.47
Current Deferred Revenue
300.86
+38.24%
217.63
+54.93%
140.47
Total Non Current Liabilities Net Minority Interest
3.82
-47.42%
7.26
-34.58%
11.10
Long Term Debt And Capital Lease Obligation
3.82
-47.42%
7.26
-34.58%
11.10
Long Term Capital Lease Obligation
3.82
-47.42%
7.26
-34.58%
11.10
Stockholders Equity
378.54
-9.16%
416.70
-2.48%
427.28
Common Stock Equity
178.66
+141.11%
-434.57
-2.49%
-423.99
Capital Stock
199.87
-76.52%
851.27
+0.00%
851.27
Common Stock
0.00
0.00
0.00
Preferred Stock
199.87
-76.52%
851.27
+0.00%
851.27
Share Issued
79.17
+1.48%
78.02
+0.00%
78.02
Ordinary Shares Number
79.17
+1.48%
78.02
+0.00%
78.02
Additional Paid In Capital
1,229.68
+1295.82%
88.10
+1.56%
86.75
Retained Earnings
-1,051.00
-101.06%
-522.74
-2.34%
-510.80
Gains Losses Not Affecting Retained Earnings
-0.02
-129.41%
0.07
+13.33%
0.06
Other Equity Adjustments
-0.02
-129.41%
0.07
+13.33%
0.06
Total Equity Gross Minority Interest
378.54
-9.16%
416.70
-2.48%
427.28
Total Capitalization
378.54
-9.16%
416.70
-2.48%
427.28
Working Capital
171.50
-48.68%
334.15
-3.35%
345.73
Invested Capital
178.66
+141.11%
-434.57
-2.49%
-423.99
Total Debt
8.04
-27.39%
11.07
-29.62%
15.73
Capital Lease Obligations
8.04
-27.39%
11.07
-29.62%
15.73
Net Tangible Assets
311.93
-11.71%
353.29
-2.81%
363.49
Tangible Book Value
112.05
+122.50%
-497.98
-2.09%
-487.79
Available For Sale Securities
113.17
Investmentin Financial Assets
113.17
0.00
Preferred Stock Equity
199.87
-76.52%
851.27
+0.00%
851.27
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Operating Cash Flow
171.44
+249.87%
49.00
+176.67%
-63.91
Cash Flow From Continuing Operating Activities
171.44
+249.87%
49.00
+176.67%
-63.91
Net Income From Continuing Operations
-528.26
-4326.89%
-11.93
+88.97%
-108.14
Depreciation Amortization Depletion
5.13
-13.73%
5.95
+5.74%
5.63
Depreciation
5.60
+5.66%
5.30
Amortization Cash Flow
0.40
+0.00%
0.40
Depreciation And Amortization
5.13
-13.73%
5.95
+5.74%
5.63
Amortization Of Intangibles
0.40
+0.00%
0.40
Other Non Cash Items
50.10
+49.24%
33.57
+41.88%
23.66
Stock Based Compensation
643.01
+86910.69%
0.74
-55.08%
1.65
Provisionand Write Offof Assets
3.06
-43.42%
5.41
+11.39%
4.86
Asset Impairment Charge
0.00
-100.00%
1.81
-82.35%
10.26
Deferred Tax
0.05
+109.06%
-0.58
-23.68%
-0.47
Deferred Income Tax
0.05
+109.06%
-0.58
-23.68%
-0.47
Change In Working Capital
-2.01
-114.92%
13.50
+43.49%
9.41
Change In Receivables
-26.63
-1887.09%
-1.34
+94.21%
-23.13
Changes In Account Receivables
-26.63
-1887.09%
-1.34
+94.21%
-23.13
Change In Inventory
-4.76
-883.39%
0.61
-94.25%
10.56
Change In Prepaid Assets
-15.78
-72.31%
-9.15
-262.01%
5.65
Change In Payables And Accrued Expense
29.41
+367.95%
-10.97
-194.96%
11.56
Change In Other Working Capital
19.64
-49.17%
38.65
+371.52%
8.20
Change In Other Current Assets
-0.18
-148.01%
0.38
-44.31%
0.68
Change In Other Current Liabilities
-3.72
+20.18%
-4.66
-13.33%
-4.11
Investing Cash Flow
-113.76
-721.25%
18.31
+1119.99%
1.50
Cash Flow From Continuing Investing Activities
-113.76
-721.25%
18.31
+1119.99%
1.50
Net PPE Purchase And Sale
-0.71
+31.86%
-1.04
+47.42%
-1.98
Purchase Of PPE
-0.71
+31.86%
-1.04
+47.42%
-1.98
Capital Expenditure
-6.06
-60.72%
-3.77
+18.24%
-4.62
Capital Expenditure Reported
-5.36
-95.90%
-2.73
-3.60%
-2.64
Net Investment Purchase And Sale
-103.70
-569.54%
22.09
+261.10%
6.12
Purchase Of Investment
-472.29
-45.52%
-324.54
+28.41%
-453.33
Sale Of Investment
368.59
+6.34%
346.63
-24.56%
459.45
Net Business Purchase And Sale
-4.00
0.00
0.00
Purchase Of Business
-4.00
0.00
0.00
Financing Cash Flow
-150.47
-6733.24%
-2.20
+26.60%
-3.00
Cash Flow From Continuing Financing Activities
-150.47
-6733.24%
-2.20
+26.60%
-3.00
Net Issuance Payments Of Debt
4.93
0.00
0.00
Issuance Of Debt
4.93
0.00
0.00
Long Term Debt Issuance
4.93
0.00
0.00
Net Long Term Debt Issuance
4.93
0.00
0.00
Net Common Stock Issuance
190.65
0.00
0.00
Common Stock Payments
-65.03
0.00
0.00
Repurchase Of Capital Stock
-65.03
0.00
0.00
Proceeds From Stock Option Exercised
9.53
+1462.13%
0.61
+23.98%
0.49
Net Other Financing Charges
-355.58
-12545.02%
-2.81
+19.47%
-3.49
Changes In Cash
-92.79
-242.51%
65.11
+199.55%
-65.41
Beginning Cash Position
302.59
+27.42%
237.47
-21.60%
302.88
End Cash Position
209.80
-30.67%
302.59
+27.42%
237.47
Free Cash Flow
165.38
+265.64%
45.23
+166.00%
-68.52
Amortization Of Securities
0.36
-32.77%
0.54
+104.99%
-10.76
Common Stock Issuance
255.68
0.00
0.00
Issuance Of Capital Stock
255.68
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category